Exploring Lipoprotein(a)

Thomas and Simon delve into the challenges of conducting primary prevention trials for drugs targeting lipoprotein(a), highlighting the potential of imaging studies as an alternative. They discuss the implications for individuals with high LP levels and the role of lifestyle modifications in managing cardiovascular risk.